During the past decade, Hôpital Purpan - Médecine Interne conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Purpan - Médecine Interne" #1 collaborator was "Celgene" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Purpan - Médecine Interne" are "Myelodysplastic Syndrome" (2 trials), "High Grade Myelodysplastic Syndrome Lesions" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Hôpital Purpan - Médecine Interne" in a lesser frequency.

Most popular intervention types in "Hôpital Purpan - Médecine Interne" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine and oral vorinostat" (1 trials), "Azacitidine combined to Lenalidomide" (1 trials), "Erlotinib" (1 trials) and "azacitidine and idarubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Purpan - Médecine Interne" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Purpan - Médecine Interne". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital Purpan - Médecine Interne, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Purpan - Médecine Interne, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".